Workflow
Anti - Aging
icon
Search documents
CORRECTION – Visionary Holdings Inc.
Globenewswire· 2026-01-14 03:36
Core Viewpoint - Visionary Holdings Inc. has released its final annual report for fiscal year 2025, highlighting a strategic transformation towards health management, anti-aging, and premium medical aesthetics, with initial revenue contributions from emerging health businesses indicating early progress in this transition [1][3][14]. Financial Performance - Total revenue for fiscal year 2025 was USD 5.04 million, a decrease of 46.2% year-over-year, primarily due to a contraction in real estate leasing operations and changes in the education policy environment [3]. - The company reported a net loss of USD 15.75 million, largely due to one-time transformation-related investments and asset impairment charges totaling approximately USD 4.70 million [4]. - Gross margin improved to 28.0%, with the education services segment achieving a gross margin of 64.4%, indicating stability in core operating efficiency [5]. - Cash flow from investing activities was USD 14.51 million, mainly from asset dispositions, while operating cash outflows decreased to USD 2.97 million from USD 4.10 million in the previous fiscal year [5]. Business Developments - Emerging health-related businesses contributed approximately 21.1% of total revenue, marking the early implementation stage of the company's business restructuring [3]. - Real estate leasing revenue was USD 2.80 million, education services revenue was USD 1.18 million, and life sciences and health-related businesses generated USD 1.06 million [8]. - The company is pursuing initiatives in health management and anti-aging, focusing on gastrointestinal health management and service-oriented offerings, with early-stage commercialization efforts in Asia [9]. - Strategic collaborations have been established with industry participants to enhance access to proprietary technologies and expand the global premium medical aesthetics service network [11]. Strategic Focus - The company aims to advance its development in high-potential segments within premium medical aesthetics and cellular rejuvenation-related businesses, with plans for commercialization and market expansion over the next two years [15]. - The AI education business remains stable, continuing to offer various educational programs while cooperating with Canadian public institutions [12]. - Future plans include optimizing the AI education ecosystem, enhancing digital student management systems, and expanding marketing efforts in key Asian markets [20].